3.90
price up icon4.28%   0.16
after-market Dopo l'orario di chiusura: 3.94 0.04 +1.03%
loading

Atea Pharmaceuticals Inc Borsa (AVIR) Ultime notizie

pulisher
12:16 PM

What drives Atea Pharmaceuticals Inc. stock priceExceptional earning trajectories - PrintWeekIndia

12:16 PM
pulisher
11:28 AM

What analysts say about Atea Pharmaceuticals Inc. stockSuperior risk-adjusted returns - PrintWeekIndia

11:28 AM
pulisher
08:17 AM

What risks could impact Atea Pharmaceuticals Inc. stock performanceHigh-yield capital appreciation - jammulinksnews.com

08:17 AM
pulisher
07:16 AM

3 Promising Penny Stocks With A Market Cap Of At Least $200M - simplywall.st

07:16 AM
pulisher
Jul 24, 2025

What analysts say about Atea Pharmaceuticals Inc. stock outlookHigh-velocity gains - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Will Atea Pharmaceuticals Inc. stock benefit from interest rate changesExceptional profit margins - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Insiders Placed Bullish Bets Worth US$5.40m - Yahoo.co

Jul 23, 2025
pulisher
Jul 23, 2025

Atea Pharmaceuticals Inc. Stock Analysis and ForecastDynamic investment growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Atea Pharmaceuticals Inc. a good long term investmentPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 15, 2025

Why Atea Pharmaceuticals Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Atea Pharmaceuticals Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Atea Pharmaceuticals Inc. stock performs during market volatilityFree Stock Movement Tracking - Newser

Jul 15, 2025
pulisher
Jun 29, 2025

Atea Pharmaceuticals announces continued advancement of global Phase 3 HCV program - European AIDS Treatment Group

Jun 29, 2025
pulisher
Jun 26, 2025

Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing - Bain Capital

Jun 26, 2025
pulisher
Jun 24, 2025

New Hepatitis C Treatment Could Slash Therapy Time to 8 Weeks as Global Phase 3 Trial Advances - Stock Titan

Jun 24, 2025
pulisher
Jun 20, 2025

Atea Pharmaceuticals Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 17, 2025

Here's Why We're Not At All Concerned With Atea Pharmaceuticals' (NASDAQ:AVIR) Cash Burn Situation - Yahoo Finance

Jun 17, 2025
pulisher
Jun 15, 2025

Bank of America Corp DE Boosts Stock Position in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Invests $75,000 in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 14, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Buys 35,053 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Shares Sold by Two Sigma Investments LP - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Jane Street Group LLC Decreases Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Public Employees Retirement System of Ohio Trims Stock Holdings in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Sells 11,900 Shares of Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World

Jun 06, 2025
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
Capitalizzazione:     |  Volume (24 ore):